|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
2 August 2023 |
|
Main ID: |
NCT02557048 |
|
Date of registration:
|
21/09/2015 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Head and Neck Cancer in Children: A Retrospective Study
|
|
Scientific title:
|
Malignant Head and Neck Tumors in Children: A Retrospective Study |
|
Date of first enrolment:
|
January 10, 2019 |
|
Target sample size:
|
120 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/ct2/show/NCT02557048 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Egypt
| | | | | | | |
|
Contacts
|
|
Name:
|
Ahmed M. Morsy, MD |
|
Address:
|
|
|
Telephone:
|
+2 01003314522 |
|
Email:
|
ahmedmohammed7829@yahoo.com |
|
Affiliation:
|
|
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients whose age less than 19 years.
- Patients diagnosed with a primary malignant tumor of the head & neck.
Exclusion Criteria:
- Patients whose age more than 18 years.
- Patients diagnosed with a malignant disease primarily arising from the bone marrow.
- Patients diagnosed with tumors of the central nervous system.
- Patients diagnosed with retinoblastoma.
Age minimum:
N/A
Age maximum:
18 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Neoplasms, Head and Neck
|
|
Cancer of the Head and Neck
|
|
Cancer of Head and Neck
|
|
Head and Neck Cancer
|
|
Head and Neck Neoplasms
|
|
Primary Outcome(s)
|
|
Event Free Survival (EFS)
[Time Frame: Participants will be retrospectively followed forward in time from the date of initiation of treatment till the primary completion date of the study, an expected average of 5 years]
|
|
Overall survival (OS)
[Time Frame: Participants will be retrospectively followed forward in time from the date of initiation of treatment till the primary completion date of the study, an expected average of 5 years]
|
|
Secondary ID(s)
|
|
Ped Head Neck Malig
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|